Parametric Portfolio Associates’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$942K Buy
39,771
+17,120
+76% +$482K ﹤0.01% 2808
2021
Q4
$775K Buy
22,651
+2,217
+11% +$70.1K ﹤0.01% 2888
2021
Q3
$362K Sell
20,434
-50,966
-71% -$2.17M ﹤0.01% 3226
2021
Q2
$3.2M Buy
71,400
+31,201
+78% +$1.03M ﹤0.01% 2154
2021
Q1
$1.04M Sell
40,199
-8,303
-17% -$210K ﹤0.01% 3146
2020
Q4
$978K Buy
+48,502
New +$1.04M ﹤0.01% 3067
2020
Q2
Sell
-17,931
Closed -$127K 3984
2020
Q1
$127K Sell
17,931
-268
-1% -$2.01K ﹤0.01% 3676
2019
Q4
$128K Buy
18,199
+644
+4% +$6.39K ﹤0.01% 3826
2019
Q3
$211K Buy
17,555
+322
+2% +$4.06K ﹤0.01% 3688
2019
Q2
$209K Buy
17,233
+106
+0.6% +$1.17K ﹤0.01% 3730
2019
Q1
$215K Sell
17,127
-1,553
-8% -$13.7K ﹤0.01% 3696
2018
Q4
$126K Sell
18,680
-702
-4% -$5.57K ﹤0.01% 3755
2018
Q3
$199K Sell
19,382
-3,775
-16% -$32.5K ﹤0.01% 3766
2018
Q2
$156K Buy
+23,157
New +$178K ﹤0.01% 3747

Other funds holding PTGX